Prognostic Impact of Intensified Maintenance Therapy on Children With Advanced Lymphoblastic Lymphoma: A Report From the Japanese Pediatric Leukemia/Lymphoma Study Group ALB-NHL03 Study-Reference-Cited by-同舟云学术

Prognostic Impact of Intensified Maintenance Therapy on Children With Advanced Lymphoblastic Lymphoma: A Report From the Japanese Pediatric Leukemia/Lymphoma Study Group ALB-NHL03 Study

Published:2015-11-19 Issue:3 Volume:63 Page:451-457
ISSN:1545-5009
Container-title:Pediatric Blood & Cancer
language:en
Short-container-title:Pediatr Blood Cancer

Author:

Sunami Shosuke¹,Sekimizu Masahiro²,Takimoto Tetsuya³,Mori Tetsuya⁴,Mitsui Tetsuo⁵,Fukano Reiji⁶,Saito Akiko Moriya⁷,Watanabe Tomoyuki⁸,Ohshima Koichi⁹,Fujimoto Junichiro³,Nakazawa Atsuko¹⁰,Kobayashi Ryoji¹¹,Horibe Keizo¹²,Tsurusawa Masahito¹³

Affiliation:

1. Department of Pediatrics; Japanese Red Cross Narita Hospital; Narita Japan

2. Department of Pediatrics; National Hospital Organization; Nagoya Medical Center; Aichi Japan

3. Clinical Research Center; National Center for Child Health and Development; Tokyo Japan

4. Department of Pediatrics; St. Marianna University School of Medicine; Kawasaki Japan

5. Department of Pediatrics; Yamagata University School of Medicine; Yamagata Japan

6. Department of Pediatrics; National Kyushu Cancer Center; Fukuoka Japan

7. Laboratory of Clinical; Epidemiological and Health Services Research; Clinical Research Center; National Hospital Organization; Nagoya Medical Center; Aichi Japan

8. Department of Nutritional Science; Faculty of Psychological and Physical Science; Aichi Gakuin University; Aichi Japan

9. Department of Pathology; School of Medicine; Kurume University; Kurume Japan

10. Department of Pathology; National Center for Child Health and Development; Tokyo Japan

11. Department of Pediatrics; Sapporo Hokuyu Hospital; Sapporo Japan

12. Clinical Research Center; National Hospital Organization; Nagoya Medical Center; Aichi Japan

13. Advanced Medical Research Center; Aichi Medical University; Aichi Japan

Publisher

Wiley

Subject

Oncology,Hematology,Pediatrics, Perinatology, and Child Health

Reference21 articles.

1. Incidence and survival rates of hematological malignancies in Japanese children and adolescents (2006-2010): Based on registry data from the Japanese Society of Pediatric Hematology;Horibe;Int J Hematol,2013

2. Diagnosis and treatment of childhood non-Hodgkin lymphoma;Reiter;Hematology Am Soc Hematol Educ Program,2007

3. Outcome of 59 children with lymphoblastic lymphoma receiving an intensive ALL-type therapy without prophylactic cranial irradiation;Tsurusawa;Jpn J Pediatr Hematol,2009

4. Outcome of children with advanced T-cell lymphoblastic lymphoma treated by ALL-type regimen containing high-dose cytarabine: Results of the Tokyo Children's Cancer Study Group Study NHL T9604: Abstract of Papers, The Second International Symposium on Childhood, Adolescent and Young Adult Non-Hodgkin's Lymphoma, New York, NY, May 18-20, 2006;Sunami;Pediatr Blood Cancer,2006

5. Inferior outcomes of stage III T lymphoblastic lymphoma relative to stage IV lymphoma and T- acute lymphoblastic leukemia: Long term analysis of the JACLS NHL T-98 protocol compared with ALL T-97 protocol;Kobayashi;Int J Haematol,2014

Cited by 17 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Mediastinal Gamma-Delta T-Cell Lymphoblastic Lymphoma Successfully Treated With Chemotherapy Alone;Journal of Pediatric Hematology/Oncology;2020-12-23

2. Successful Outcomes of Newly Diagnosed T Lymphoblastic Lymphoma: Results From Children’s Oncology Group AALL0434;Journal of Clinical Oncology;2020-09-10

3. The effect of graft‐versus‐host disease on outcomes after allogeneic stem cell transplantation for refractory lymphoblastic lymphoma in children and young adults;Pediatric Blood & Cancer;2019-12-26

4. Multiple heterogeneous bone invasions of B lymphoblastic lymphoma with the TCF3/PBX1 fusion gene: a case report;International Journal of Hematology;2019-12-11

5. Clinical Features, Prognosis, Diagnostic Approaches and Treatment of Multiple Primary Malignancies in the Digestive System;Anticancer Research;2019-12